Saturday's industry events
Learning studios and industry symposia planned for Saturday.
For additional information about industry events taking place during #AHA21, see the Industry Highlights channel.
6:30-7:30 a.m. EST
- Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science and Strategies for Early Diagnosis and Tailored Treatment
11-11:45 a.m. EST
- The Heart of the Matter: A New Treatment for Slowing CKD Progression and Reducing CV Risk in Patients With CKD Associated With T2D
- Heart Failure Isn’t the Only Type of Failure in Cardiology: Addressing the Misdiagnosis of HCM
11 a.m.-12:30 p.m. EST
- Potential Impact of Virtual Longitudinal Studies
12:30-1:15 p.m. EST
- A Focus on Very High-Risk Patients in the Acute Setting: Understanding Vulnerable Plaque and Prioritizing LDL-C
- Jardiance® (empagliflozin) Tablets: A Review of the Latest Data
- Your Elderly Heart Failure Patient: Considerations, Management, and Future Directions
1:45-2:15 p.m. EST | Roundtable
- What’s New When It Comes to Diagnosing and Treating Hypertrophic Cardiomyopathy
1:45-2:30 p.m. EST
- Clinical Insights in CAD and/or PAD: Reducing the Risk of Major Cardiovascular Events
- Opportunities to Improve Health Outcomes in ASCVD: A Focus on Population Health and a Call to Action for Health Equity
3-4:30 p.m. EST
- NHLBI Company Showcase: A live virtual pitch exhibition featuring six NHLBI-funded companies.
5:30-6:30 p.m. EST
GLP-1 RAs in Type 2 Diabetes: Clinical and Practical Considerations in Cardiology
5:30-7 p.m. EST
Managing the Heart Failure Patient With Reduced Ejection Fraction: New Perspectives and Emerging Evidence
6:30-8 p.m. EST
Cases and Conversations™: Making the Most of Effective Antithrombotic Strategies in Patients with CAD and PAD
7:30-9 p.m. EST
Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack: A Personalized Approach
These events are not part of the official Scientific Sessions 2021 as planned by the AHA Committee on Scientific Sessions Program.